General MedicationsOPHTHALMICStandard
BIMATOPROST
BIMATOPROST
Standard Dose
0.01%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview BIMATOPROST is listed in Drugs@FDA under application 218196 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BIMATOPROST Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.01% Sponsor MANKIND PHARMA Submission history Latest submission status date: 2025-03-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview BIMATOPROST is listed in Drugs@FDA under application 218196 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BIMATOPROST Form and strength SOLUTION/DROPS;OPHTHALMIC - 0.01% Sponsor MANKIND PHARMA Submission history Latest submission status date: 2025-03-17 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.